AU2002221779A1 - Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation - Google Patents

Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation

Info

Publication number
AU2002221779A1
AU2002221779A1 AU2002221779A AU2177902A AU2002221779A1 AU 2002221779 A1 AU2002221779 A1 AU 2002221779A1 AU 2002221779 A AU2002221779 A AU 2002221779A AU 2177902 A AU2177902 A AU 2177902A AU 2002221779 A1 AU2002221779 A1 AU 2002221779A1
Authority
AU
Australia
Prior art keywords
medicinal products
products according
sulfonamide
glibenclamide
biguanide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221779A
Other languages
English (en)
Inventor
Nathalie Cugnardey
Nicolas Wiernsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002221779A1 publication Critical patent/AU2002221779A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002221779A 2000-11-22 2001-10-29 Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation Abandoned AU2002221779A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0015066 2000-11-22
FR0015066A FR2816841B1 (fr) 2000-11-22 2000-11-22 Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
PCT/EP2001/012492 WO2002041879A2 (en) 2000-11-22 2001-10-29 Antidiabetic compositions containing a biguanide and a sulfonamide

Publications (1)

Publication Number Publication Date
AU2002221779A1 true AU2002221779A1 (en) 2002-06-03

Family

ID=8856750

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002221779A Abandoned AU2002221779A1 (en) 2000-11-22 2001-10-29 Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
AU2002222026A Abandoned AU2002222026A1 (en) 2000-11-22 2001-11-22 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002222026A Abandoned AU2002222026A1 (en) 2000-11-22 2001-11-22 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same

Country Status (18)

Country Link
US (1) US20040039031A1 (cs)
EP (1) EP1335731A2 (cs)
JP (1) JP2004513962A (cs)
KR (1) KR20030051858A (cs)
CN (1) CN1474696A (cs)
AU (2) AU2002221779A1 (cs)
BR (1) BR0115506A (cs)
CA (1) CA2429257A1 (cs)
CZ (1) CZ20031449A3 (cs)
FR (1) FR2816841B1 (cs)
HU (1) HUP0302620A3 (cs)
MX (1) MXPA03004431A (cs)
NO (1) NO20032287D0 (cs)
PL (1) PL361189A1 (cs)
RU (1) RU2003116890A (cs)
SK (1) SK6452003A3 (cs)
WO (2) WO2002041879A2 (cs)
ZA (1) ZA200304766B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1515701B1 (en) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
EP1752147A4 (en) * 2004-06-04 2007-10-31 Kowa Co MEDICINE FOR THE PREVENTION OR TREATMENT OF DIABETES
WO2007105730A1 (ja) * 2006-03-13 2007-09-20 Kyowa Hakko Kogyo Co., Ltd. インスリン抵抗性改善剤
PL2106260T3 (pl) * 2007-01-25 2018-06-29 NAIA Metabolic, Inc. Środki uwrażliwiające na insulinę i sposoby leczenia
EP2273989A4 (en) * 2008-04-07 2013-05-01 Interface Biologics Inc POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
CA2312990C (en) * 1997-12-08 2008-04-29 Bristol-Myers Squibb Company Novel salts of metformin and method
ATE250418T1 (de) * 1998-07-15 2003-10-15 Merck Sante Sas Tabletten enthaltend eine kombination von glibenclamid und metformin

Also Published As

Publication number Publication date
NO20032287L (no) 2003-05-21
CZ20031449A3 (cs) 2003-09-17
WO2002041879A2 (en) 2002-05-30
CN1474696A (zh) 2004-02-11
ZA200304766B (en) 2004-09-20
HUP0302620A3 (en) 2005-06-28
WO2002041897A2 (fr) 2002-05-30
AU2002222026A1 (en) 2002-06-03
US20040039031A1 (en) 2004-02-26
PL361189A1 (en) 2004-09-20
WO2002041879A3 (en) 2003-05-22
NO20032287D0 (no) 2003-05-21
WO2002041897A3 (fr) 2003-05-30
FR2816841B1 (fr) 2004-02-06
RU2003116890A (ru) 2004-12-10
CA2429257A1 (en) 2002-05-30
FR2816841A1 (fr) 2002-05-24
EP1335731A2 (en) 2003-08-20
MXPA03004431A (es) 2003-08-19
SK6452003A3 (en) 2003-09-11
HUP0302620A2 (hu) 2003-11-28
JP2004513962A (ja) 2004-05-13
KR20030051858A (ko) 2003-06-25
BR0115506A (pt) 2003-10-21

Similar Documents

Publication Publication Date Title
RU2245709C2 (ru) Применение аналогов сибутрамина для профилактики сахарного диабета
US7060295B2 (en) Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
US5789401A (en) High-dose chromium/biotin treatment of type II diabetes
JP2007538015A (ja) インスリン抵抗性を治療するための薬剤併用による使用方法
US20200315993A1 (en) Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes
USRE39480E1 (en) Chromium/biotin treatment of type II diabetes
CA2278854A1 (en) Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes
RU2451506C1 (ru) Комбинация для лечения сахарного диабета и его осложнений
UA70303C2 (uk) Комбінація, що містить тіазолідиндіон, засіб стимуляції секреції інсуліну та дигуанід, спосіб лікування цукрового діабету
EP0313654B1 (en) Drug for prophylaxis and treatment of hepatopathy
US20040039031A1 (en) Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
CA2590883A1 (en) Medicinal composition for treating diabetes
US20130108673A1 (en) Co-Therapy for Diabetic Conditions
RU2362548C1 (ru) Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения
WO2005084660A1 (ja) ミトコンドリア病予防と対策
CN104582701A (zh) 减轻体重的方法
CN113924096A (zh) 低剂量三联组合制剂
RU2709491C1 (ru) Новые производные ванадия, обладающие гипогликемической активностью
RU2333760C2 (ru) Твердая дозированная лекарственная форма для лечения сахарного диабета
RU2247561C1 (ru) Комбинированная фармацевтическая композиция с противотуберкулёзным действием
WO2003045387A1 (en) Pharmaceutical composition with combined active agents containing metformin and a hydroxylamine derivative
AU2002302012B2 (en) Chromim/biotin treatment of type II diabetes
RU2449797C1 (ru) Противотуберкулезное лекарственное средство и способ лечения
EP4364735A1 (en) Pharmaceutical composition and use thereof
RU2359677C2 (ru) Оральные таблетки с модифицированным высвобождением и способ их получения